To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

POISE 2 (Part 1): The safety and efficacy of aspirin following non-cardiac surgery

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
October 2014

POISE 2 (Part 1): The safety and efficacy of aspirin following non-cardiac surgery

Vol: 3| Issue: 10| Number:61| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A

Aspirin in patients undergoing noncardiac surgery

N Engl J Med. 2014 Apr 17;370(16):1494-503. doi: 10.1056/NEJMoa1401105. Epub 2014 Mar 31

Contributing Authors:
PJ Devereaux M Mrkobrada DI Sessler K Leslie P Alonso-Coello A Kurz JC Villar A Sigamani BM Biccard CS Meyhoff JL Parlow G Guyatt A Robinson AX Garg RN Rodseth F Botto G Lurati Buse D Xavier MT Chan M Tiboni D Cook PA Kumar P Forget

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

10,010 patients with, or at risk for, major vascular disease, and undergoing non-cardiac surgery were randomized to receive either aspirin or placebo (both with and without clonidine) as part of the Perioperative Ischemic Evaluation 2 (POISE-2) trial. This report, Part 1, summarizes the data pertaining to the safety and efficacy of aspirin, while clonidine-related data is summarized in Part 2. Res...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue